| [1] |
Kaya E, Sikka SC, Gur S. A Comprehensive Review of Metabolic Syndrome Affecting Erectile Dysfunction[J]. J Sex Med, 2015, 12(4):856-875.
|
| [2] |
Tanner RM, Brown TM, Muntner P. Epidemiology of Obesity, the Metabolic Syndrome, and Chronic Kidney Disease[J]. Curr Hypertens Rep, 2012, 14(2):152-159.
|
| [3] |
Sanjay S, Bharti GS, Manish G, et al.Metabolic syndrome: An independent risk factor for erectile dysfunction[J]. Indian J Endocr Metab, 2015, 19(2):277-282.
|
| [4] |
Besiroglu H, Otunctemur A, Ozbek E.The Relationship Between Metabolic Syndrome, Its Components, and Erectile Dysfunction: A Systematic Review and a Meta-Analysis of Observational Studies[J]. J Sex Med, 2015, 12(6):1309-1318.
|
| [5] |
Thang VV, Hue DH, Nhan PTN. Prevalence and Associated Factors of Erectile Dysfunction among Married Men in Vietnam[J]. Frontiers in Public Health, 2017, 5:UNSP 94.
|
| [6] |
Shi MD, Chao JK, Ma MC, et al. Factors Associated with Sex Hormones and Erectile Dysfunction in Male Taiwanese Participants with Obesity[J].J Sex Med, 2014, 11(1):230-239.
|
| [7] |
Corona G, Rastrelli G, Filippi S, et al. Erectile dysfunction and central obesity: an Italian perspective[J]. AJA, 2014, 16(4):581-591.
|
| [8] |
Andersen JM, Herning H, Aschim EL, et al.Body mass index is associated with impaired semen characteristics and reduced levels of anti-Müllerian hormone across a wide weight range[J]. PLoS One, 2015, 10(6):e0130210.
|
| [9] |
Podlasek CA, Mulhall J, Davies K, et al. Translational Perspective on the Role of Testosterone in Sexual Function and Dysfunction[J]. J Sex Med, 2016, 13(8):1183-1198.
|
| [10] |
Vanhoutte PM, Shimokawa H, Feletou M, et al.Endothelial dysfunction and vascular disease-a 30 th anniversary update[J]. Acta Physiologica, 2017. 219(1):22-96.
|
| [11] |
Musicki B, Burnett AL. Role of Oxidative Stress in ED: Unraveling the Molecular Mechanism[M]. Humana Press, 2012:617-643.
|
| [12] |
Skeldon SC, Detsky AS, Goldenberg SL, et al. Erectile Dysfunction and Undiagnosed Diabetes, Hypertension, and Hypercholesterolemia[J]. Annals of Family Medicine, 2015, 13(4):331-335.
|
| [13] |
Kim IG, Piao S, Lee JY, et al. Effect of an Adipose-Derived Stem Cell and Nerve Growth Factor-Incorporated Hydrogel on Recovery of Erectile Function in a Rat Model of Cavernous Nerve Injury[J]. Tissue engineering Part A, 2013, 19(1-2):14-23.
|
| [14] |
张留弟，李群益，施孝金.血管内皮功能障碍与2型糖尿病研究进展[J].上海医药, 2014(23):45-48.
|
| [15] |
Castela A, Costa C. Molecular mechanisms associated with diabetic endothelial-erectile dysfunction[J]. Nature Reviews Urology, 2016, 13(5):266-274.
|
| [16] |
Matsui H, Sopko NA, Hannan JL, et al. Pathophysiology of Erectile Dysfunction[J]. Current Drug Targets, 2015, 16(5):411-419.
|
| [17] |
Li H, Qi T, Huang Z, et al. Mechanism research of improvement of diabetic ED rats' erectile function by vacuum erection device through anti-oxidative stress[J]. Int J Clin Exp Med, 2017, 10(3):4629-4638.
|
| [18] |
Jiang XP, Li FP, Xuan XJ, et al. Etiologic factors of erectile dysfunction in men with type 2 diabetes mellitus[J]. National journal of andrology, 2012, 18(10):904-908.
|
| [19] |
Zhang LY, He W, Wan JX, et al. Hypogonadism and the quality of life in male patients with type-2 diabetes mellitus[J]. National Journal of Andrology, 2016, 22(12):1088-1094.
|
| [20] |
Kostis JB, Dobrzynski JM.The Effect of Statins on Erectile Dysfunction: A Meta-Analysis of Randomized Trials[J]. J Sex Med, 2014, 11(7):1626-1635.
|
| [21] |
Yao F, Huang Y, Zhang Y, et al. Subclinical endothelial dysfunction and low-grade inflammation play roles in the development of erectile dysfunction in young men with low risk of coronary heart disease[J]. Int J Androl, 2012, 35(5):653-659.
|
| [22] |
Fraga-Silva RA, Costa-Fraga FP, Faye Y, et al. An Increased Arginase Activity Is Associated with Corpus Cavernosum Impairment Induced by Hypercholesterolemia[J]. J Sex Med, 2014, 11(5):1 173-1181.
|
| [23] |
Li R, Cui K, Wang T, et al. Hyperlipidemia impairs erectile function in rats by causing cavernosal fibrosis[J]. Andrologia, 2017, 49(7):e12693.
|
| [24] |
Maiorino MI, Bellastella G, Esposito K.Diabetes and sexual dysfunction: current perspectives [J]. Diabetes,metabolic syndrome and obesity: targets and therapy, 2014, 7:95-105.
|
| [25] |
Huang YC, Ning H, Shindel AW, et al. The Effect of Intracavernous Injection of Adipose Tissue-Derived Stem Cells on Hyperlipidemia-Associated Erectile Dysfunction in a Rat Model[J]. J Sex Med, 2010, 7(4):1391-1400.
|
| [26] |
Ning L, Yang L. Hypertension might be a risk factor for erectile dysfunction: a meta-analysis[J]. andrologia, 2017, 49(4):e12644.
|
| [27] |
Cordero A, Bertomeu-Martinez V, Mazon P,et al.Erectile Dysfunction in High Risk Hypertensive Patients Treated with Beta-Blockade Agents[J].Cardiovascular Therapeutics, 2010, 28(1):15-22.
|
| [28] |
Nunes KP, Labazi H, Webb RC. New insights into hypertension-associated erectile dysfunction[J]. Curr Opin Nephrol Hy, 2012, 21(2): 163-170.
|
| [29] |
Hoffman BM, Sherwood A, Smith PJ, et al. Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men[J]. Int J Impot Res, 2010, 22(1):30-35.
|
| [30] |
Ashcheulova TV, Gerasimchuk NN. Peculiarities of the influence of antihypertensive therapy on endothelial function, oxidative stress and immune activation in obese patients[J]. Regulatory Mechanisms in Biosystems, 2017, 8(2):152-156.
|
| [31] |
Wang B, Jiang J, Fan Z, et al. Expression of Sphingosine 1-Phosphate 1-3 on Penile Cavernous Tissue in Hypertensive and Normotensive Rats[J].Urology, 2014, 84(2):490.e7.
|
| [32] |
Gur S, Kadowitz PJ, Gurkan L, et al. Chronic inhibition of nitric-oxide synthase induces hypertension and erectile dysfunction in the rat that is not reversed by sildenafil[J]. Bju Int, 2010, 106(1):78-83.
|